← back to search

Michael Gajhede

University of Copenhagen · DK
Area of research
Biotechnology · Cellular and Molecular Neuroscience
Research interest
Research interests include Enzyme Production and Characterization, Neuroscience and Neuropharmacology Research, Enzyme Structure and Function, and Receptor Mechanisms and Signaling.
h-index
47
citations
8,002
works
323
NIH funding
primary concept
email

Recent publications

Small-molecule modulators of tumor necrosis factor signaling
Drug Discovery Today 2023cited by 33position: middledoi
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
Journal of Medicinal Chemistry 2021cited by 56position: middledoi
Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 Receptors
Molecular Pharmacology 2015cited by 30position: middledoi
Crystal Structure and Pharmacological Characterization of a Novel N-Methyl-d-aspartate (NMDA) Receptor Antagonist at the GluN1 Glycine Binding Site
Journal of Biological Chemistry 2013cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kasper B. Hansen · University of Montana2 papers (2013–2015) · 2 papers (2021–2023)Trine Kvist · Novo Nordisk (Denmark)2 papers (2013–2015)J.S. Kastrup · University of Copenhagen2 papers (2013–2015)Stephen F. Traynelis · Emory University2 papers (2013–2015) · 2 papers (2021–2023)Roberta Brambilla · University of Miami2 papers (2021–2023)Lars Olsen · University of Copenhagen1 papers (2015–2015) · 1 papers (2023–2023)Grzegorz M. Popowicz · Technical University of Munich1 papers (2021–2021) · 1 papers (2021–2021)Feng Yi · Ministry of Education1 papers (2015–2015) · 1 papers (2021–2021)Jacob Pøhlsgaard · University of Copenhagen1 papers (2015–2015)Shashank M. Dravid · Texas A&M University1 papers (2015–2015) · 1 papers (2021–2021) · 1 papers (2023–2023) · 1 papers (2021–2021)Natalie L. Kurtkaya · University of Copenhagen1 papers (2015–2015) · 1 papers (2021–2021)